Quick answers
- What is Lutathera?
- Lutathera is a brand name of Lutetium lu 177 dotatate, a prescription medicine. The FDA NDC Directory lists 1 Lutathera product in 1 strength and form.
- Who makes Lutathera?
- Aaa USA Inc holds the FDA application for Lutathera (NDA208700, approved January 26, 2018).
- Is there a generic or store brand of Lutathera?
- Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a Lutathera product. Ask your pharmacist whether one is right for you.
- Has Lutathera been recalled?
- No recall linked to Lutathera products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Lutathera is
Each Lutathera product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lutetium lu 177 dotatate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| lutetium oxodotreotide LU-177 10 mCi/mL injection (intravenous) | Lutathera | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lutetium lu 177 dotatate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA208700 | Aaa USA Inc | January 26, 2018 | 1 |
Companies that list Lutathera
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lutathera products.
Recalls
No recall linked to Lutathera products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.